Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,599,925
-
Share change
-
-1,644,139
-
Total reported value
-
$25,612,341
-
Put/Call ratio
-
91%
-
Price per share
-
$3.37
-
Number of holders
-
70
-
Value change
-
-$6,003,706
-
Number of buys
-
41
-
Number of sells
-
40
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q2 2020
As of 30 Jun 2020,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,599,925 shares.
The largest 10 holders included
ETF MANAGERS GROUP, LLC, VANGUARD GROUP INC, Ikarian Capital, LLC, ZEKE CAPITAL ADVISORS, LLC, BlackRock Inc., Prentice Capital Management, LP, AdvisorShares Investments LLC, Mirae Asset Global Investments Co., Ltd., JPMORGAN CHASE & CO, and MILLENNIUM MANAGEMENT LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.